Cero Therapeutics Holdings Stock Price on May 21, 2024
| CEROW Stock | 0.01 0 14.29% |
If you're considering investing in CERo Stock, it is important to understand the factors that can impact its price. As of today, the current price of CERo Therapeutics stands at 0.01, as last reported on the 22nd of December, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. CERo Therapeutics is out of control given 3 months investment horizon. CERo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 4.67% are justified by taking the suggested risk. Use CERo Therapeutics mean deviation of 26.34, and Risk Adjusted Performance of 0.1212 to evaluate company specific risk that cannot be diversified away.
Common Stock Shares Outstanding is likely to climb to about 9.7 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (13.5 M). . Price Earnings Ratio is likely to climb to about (26.9 K) in 2024. Price Book Value Ratio is likely to climb to -4.8 in 2024. CERo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CERo |
Sharpe Ratio = 0.13
| Best Portfolio | Best Equity | CEROW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 35.93 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.67 actual daily | 93 93% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average CERo Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CERo Therapeutics by adding it to a well-diversified portfolio.
Book Value (2.27) | Shares Float 22.5 M | Shares Short Prior Month 15.6 K | Shares Short 133.1 K |
Related Headline
Valneva SE Headline on 21st of May 2024
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Sc... by benzinga.com
Saint-Herblain , May 21, 2024 Valneva SE , a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer and Executive
CERo Therapeutics Valuation on May 21, 2024
It is possible to determine the worth of CERo Therapeutics on a given historical date. On May 21, 2024 CERo was worth 0.0575 at the beginning of the trading date compared to the closed value of 0.0575. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CERo Therapeutics stock. Still, in general, we apply an absolute valuation method to find CERo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CERo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CERo Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.07 | 0.07 | 0.07 | 0.07 | 25.00 | |
05/21/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 91,225 |
| 0.06 | 0.06 | 0.06 | 0.06 | 2,465 |
| Backtest CERo Therapeutics | | | CERo Therapeutics History | | | CERo Therapeutics Valuation | Previous | Next |
CERo Therapeutics Trading Date Momentum on May 21, 2024
| On May 22 2024 CERo Therapeutics Holdings was traded for 0.06 at the closing time. The highest daily price throughout the period was 0.06 and the lowest price was 0.06 . The daily volume was 2.5 K. The net trading volume on 05/22/2024 added to the next day price reduction. The overall trading delta to closing price of the next trading day was 0.70% . The overall trading delta to current closing price is 44.17% . |
CERo Therapeutics Fundamentals Correlations and Trends
By evaluating CERo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CERo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CERo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CERo Therapeutics Stock history
CERo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CERo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CERo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CERo Therapeutics stock prices may prove useful in developing a viable investing in CERo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 6.5 M | 9.7 M |
CERo Therapeutics Stock Technical Analysis
CERo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CERo Therapeutics Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
CERo Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CERo Therapeutics December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how CERo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CERo Therapeutics shares will generate the highest return on investment. By undertsting and applying CERo Therapeutics stock market strength indicators, traders can identify CERo Therapeutics Holdings entry and exit signals to maximize returns
CERo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CERo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CERo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CERo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1212 | |||
| Jensen Alpha | 5.11 | |||
| Total Risk Alpha | 4.04 | |||
| Sortino Ratio | 0.1969 | |||
| Treynor Ratio | (1.73) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for CERo Stock Analysis
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.